ABSTRACT
The objective was to evaluate the digestive tract characteristics, metabolizability and nutrient retention of broilers fed diets supplemented with enzyme complex (EC). To evaluate the characteristics of the digestive tract 600 female Cobb 500 birds were used, distributed in a completely randomized design, with 5 inclusion levels of the EC (0; 100, 200, 300 and 400 g/ton) and 6 replicates of 20 birds each. To evaluate the metabolizability and the retention of nutrients 200 female Cobb 500 birds at 15 days of age were used, distributed in a completely randomized design with 5 levels of supplementation of the EC and 4 replicates of 10 birds each. No significant effects (P>0.05) were observed for the supplementation of the EC in the intestinal pH, digestive organ weight, intestinal length and metabolizable coefficients of dry matter and crude protein. The metabolizable coefficient of ethereal extract was influenced in a quadratic decreasing form (P<0.01). The metabolizable coefficients of calcium (Ca) and phosphorus (P) were influenced in a quadratic increase (P<0.01), resulting in increased Ca retention in 21.39% and P in 9.56%. Supplementation of the EC in broiler diets improves the metabolizability and retention of P and Ca, without affecting the other parameters evaluated.(AU)
Subject(s)
Animals , Nutrients/administration & dosage , Chickens/metabolism , Gastrointestinal Tract/metabolism , Enzymes/administration & dosage , Peptide Hydrolases , Dietary Supplements/analysis , CellulasesABSTRACT
Conocida es la influencia de la fibra dietaria sobre los efectos mecánicos a nivel gastrointestinal, la composición y modulación de la microbiota intestinal y su función en la actividad metabólica y nutricional en adultos. En niños y adolescentes estos efectos son menos conocidos, generando interesantes áreas de investigación y desarrollo científico que nos puedan entregar mayor conocimiento de sus repercusiones a nivel fisiológicos y fisiopatológicos. Esta revisión tiene como objetivo entregar información actualizada sobre las diferentes clasificaciones de fibra, sus principales funciones digestivas y metabólicas, así como las recomendaciones de ingesta diaria en pediatría.
Among adults, the influence of dietary fiber on mechanical effects at the gastrointestinal level, the composition and modulation of the intestinal microbiota and function in the metabolic and nutritional activity is known. However, in children and adolescents, these effects are less known, generating interesting areas of research and development that could provide additional knowledge at the physiological and pathophysiological level. The aim of this review was to provide updated information about the different classifications of fiber, the principal digestive and metabolic functions, as well as recommendations for daily intake for pediatric populations.
Subject(s)
Humans , Child , Dietary Fiber/administration & dosage , Dietary Fiber/classification , Gastrointestinal Tract/physiology , Gastrointestinal Tract/metabolism , Recommended Dietary Allowances , Whole GrainsABSTRACT
The gut microbiota is a group of over 38 trillion bacterial cells in the human microbiota that plays an important role in the regulation of human metabolism through its symbiotic relationship with the host. Changes in the gut microbial ecosystem are associated with increased susceptibility to metabolic disease in humans. However, the composition of the gut microbiota in those with type 2 diabetes mellitus and in the pathogenesis of metabolic diseases is not well understood. This article reviews the relationship between environmental factors and the gut microbiota in individuals with type 2 diabetes mellitus. Finally, we discuss the goal of treating type 2 diabetes mellitus by modifying the gut microbiota and the challenges that remain in this area.
Subject(s)
Humans , Gastrointestinal Tract/microbiology , Diabetes Mellitus, Type 2/microbiology , Microbiota/physiology , Gastrointestinal Microbiome , Ecosystem , Gastrointestinal Tract/metabolism , Diabetes Mellitus, Type 2/metabolismABSTRACT
Abstract Hypoxia occurs in the splanchnic region during exercise associated with sympathetic activity. In the elderly, vascular insufficiency and low vascular endothelial growth factor (VEGF) expression are observed. Compared to young people, sympathetic signals of older individuals are blunted and more resistant to splanchnic blood flow alterations during exercise. VEGF induces vasodilation responses and hence may retain blood in the splanchnic vascular bed. We hypothesized that regular mild-intensity exercise triggers weak VEGF expression in the digestive tract of the elderly. The effects of exercise on the levels of VEGF, superoxide dismutase (SOD), glutathione peroxidase (GPx), malondialdehyde (MDA) and total antioxidant capacity (T-AOC) in the stomach, jejunum, ileum and colon tissues were evaluated. With exercise, the VEGF levels in the stomach and colon increased. Although the SOD, GPx, and MDA levels decreased in the stomach, they increased in the colon. T-AOC increased in the stomach and there was no change in the jejunum, ileum and colon. The hypoperfusion during exercise was not equal in all regions of the gastrointestinal tract in the aged subjects. Hypoxia and other exercise-related mechanisms could have led to this VEGF induction. The stomach, jejunum, and ileum might have developed resistance to ischemia. The induction of VEGF may be beneficial in aging-associated impaired gastrointestinal homeostasis and neovascularization.
Subject(s)
Animals , Male , Rats , Superoxide Dismutase/blood , Exercise/physiology , Gastrointestinal Tract/metabolism , Vascular Endothelial Growth Factors/metabolism , Glutathione Peroxidase/blood , Malondialdehyde/blood , Vasodilation , Rats, Sprague-Dawley , Exercise TestABSTRACT
Immunoglobulin Y (IgY) is an effective orally administered antibody used to protect against various intestinal pathogens, but which cannot tolerate the acidic gastric environment. In this study, IgY was microencapsulated by alginate (ALG) and coated with chitooligosaccharide (COS). A response surface methodology was used to optimize the formulation, and a simulated gastrointestinal (GI) digestion (SGID) system to evaluate the controlled release of microencapsulated IgY. The microcapsule formulation was optimized as an ALG concentration of 1.56% (15.6 g/L), COS level of 0.61% (6.1 g/L), and IgY/ALG ratio of 62.44% (mass ratio). The microcapsules prepared following this formulation had an encapsulation efficiency of 65.19%, a loading capacity of 33.75%, and an average particle size of 588.75 μm. Under this optimum formulation, the coating of COS provided a less porous and more continuous microstructure by filling the cracks on the surface, and thus the GI release rate of encapsulated IgY was significantly reduced. The release of encapsulated IgY during simulated gastric and intestinal digestion well fitted the zero-order and first-order kinetics functions, respectively. The microcapsule also allowed the IgY to retain 84.37% immune-activity after 4 h simulated GI digestion, significantly higher than that for unprotected IgY (5.33%). This approach could provide an efficient way to preserve IgY and improve its performance in the GI tract.
Subject(s)
Alginic Acid/chemistry , Chitin/chemistry , Chitosan , Delayed-Action Preparations , Digestion , Drug Compounding , Drug Liberation , Gastrointestinal Tract/metabolism , Immunoglobulins/metabolism , OligosaccharidesABSTRACT
HIV infection induces alterations in almost all immune cell populations, mainly in CD4+ T cells, leading to the development of opportunistic infections. The gut-associated lymphoid tissue (GALT) constitutes the most important site for viral replication, because the main target cells, memory T-cells, reside in this tissue. It is currently known that alterations in GALT are critical during the course of the infection, as HIV-1 induces loss of tissue integrity and promotes translocation of microbial products from the intestinal lumen to the systemic circulation, leading to a persistent immune activation state and immune exhaustion. Although antiretroviral treatment decreases viral load and substantially improves the prognosis of the infection, the alterations in GALT remains, having a great impact on the ability to establish effective immune responses. This emphasizes the importance of developing new therapeutic alternatives that may promote structural and functional integrity of this tissue. In this regard, therapy with probiotics/prebiotics has beneficial effects in GALT, mainly in syndromes characterized by intestinal dysbiosis, including the HIV-1 infection. In these patients, the consumption of probiotics/prebiotics decreased microbial products in plasma and CD4+ T cell activation, increased CD4+ T cell frequency, in particular Th17, and improved the intestinal flora. In this review, the most important findings on the potential impact of the probiotics/prebiotics therapy are discussed.
Subject(s)
Humans , HIV Infections/diet therapy , Probiotics/administration & dosage , Gastrointestinal Tract/virology , Prebiotics/administration & dosage , Lymphoid Tissue/virology , CD4-Positive T-Lymphocytes , Viral Load , Gastrointestinal Tract/metabolism , Lymphoid Tissue/metabolismABSTRACT
Autism spectrum disorders (ASDs) are characterized by deficits in the individual’s ability to socialize, communicate, and use the imagination, in addition to stereotyped behaviors. These disorders have a heterogenous phenotype, both in relation to symptoms and regarding severity. Organic problems related to the gastrointestinal tract are often associated with ASD, including dysbiosis, inflammatory bowel disease, exocrine pancreatic insufficiency, celiac disease, indigestion, malabsorption, food intolerance, and food allergies, leading to vitamin deficiencies and malnutrition. In an attempt to explain the pathophysiology involved in autism, a theory founded on opioid excess has been the focus of various investigations, since it partially explains the symptomatology of the disorder. Another hypothesis has been put forward whereby the probable triggers of ASDs would be related to the presence of bacteria in the bowel, oxidative stress, and intestinal permeability. The present update reviews these hypotheses.
Subject(s)
Humans , Opioid Peptides/adverse effects , Opioid Peptides/metabolism , Autism Spectrum Disorder/etiology , Autism Spectrum Disorder/metabolism , Gastrointestinal Diseases/metabolism , Sulfhydryl Compounds/metabolism , Oxidative Stress , Opioid Peptides/analysis , Gastrointestinal Tract/physiopathology , Gastrointestinal Tract/metabolism , Gastrointestinal Tract/microbiology , Autism Spectrum Disorder/physiopathology , Gastrointestinal Microbiome , Gastrointestinal Diseases/physiopathologyABSTRACT
BACKGROUND: Testis-expressed sequence 101 (TEX101) was found to be highly expressed in testis and involved in acrosome reaction in previous studies. Recently, the metastasis suppressor function of TEX101 in cancer was disclosed, but the comprehensive investigation of its expression has rarely been reported. In this study, the expression features of TEX101 in normal human organs and seminoma were systematically analyzed. RESULTS: Immunohistochemistry demonstrated intense staining of TEX101 in human testis tissues; however, its expression in 27 other types of normal human organs, including the ovary, was negligible. Higher expression of TEX101 was observed in the spermatocytes and spermatids of the testis, but relatively lower staining was detected in spermatogonia. Western blotting showed a single TEX101 band of 38 kDa in human testis, but it did not correspond to the predicted molecular weight of its mature form at 21 KDa. Furthermore, we examined seminoma tissues by immunohistochemistry and found that none of the 36 samples expressed TEX101. CONCLUSIONS: Our data confirmed TEX101 to be a testis protein that could be related to the maturation process of male germ cells. The lack of TEX101 in seminoma indicated its potential role in tumor progression. This characteristic expression of TEX101 could provide a valuable reference for understanding its biological functions.
Subject(s)
Humans , Male , Female , Seminiferous Epithelium/metabolism , Testicular Neoplasms/metabolism , Seminoma/metabolism , Membrane Proteins/metabolism , Organ Specificity/physiology , Ovary/metabolism , Seminiferous Epithelium/pathology , Sperm Maturation/physiology , Spermatozoa/growth & development , Testicular Neoplasms/pathology , Testis/metabolism , Testis/pathology , Immunohistochemistry , Cell Differentiation , Blotting, Western , Seminoma/pathology , Gastrointestinal Tract/metabolism , Epithelium/metabolism , Lymphoid Tissue/metabolism , Nerve Tissue/metabolismABSTRACT
Mosquitoes secrete saliva that contains biological substances, including anticoagulants that counteract a host's hemostatic response and prevent blood clotting during blood feeding. This study aimed to detect heparin, an anticoagulant in Aedes togoi using an immunohistochemical detection method, in the salivary canal, salivary gland, and midgut of male and female mosquitoes. Comparisons showed that female mosquitoes contained higher concentrations of heparin than male mosquitoes. On average, the level of heparin was higher in blood-fed female mosquitoes than in non-blood-fed female mosquitoes. Heparin concentrations were higher in the midgut than in the salivary gland. This indicates presence of heparin in tissues of A. togoi.
Subject(s)
Animals , Female , Male , Aedes/metabolism , Anticoagulants/isolation & purification , Blood Coagulation/physiology , Gastrointestinal Tract/metabolism , Heparin/isolation & purification , Salivary Ducts/metabolism , Salivary Glands/metabolismABSTRACT
PURPOSE: To evaluate the intrauterine growth restriction (IUGR) by the expression of IR-β, IRS-1, IRS-2, IGF-IRβ and Ikappaβ in experimental model of gastroschisis. METHODS: Pregnant rats at 18.5 days of gestation were submitted to surgery to create experimental fetal gastroschisis (term = 22 days) were divided in three groups: gastroschisis (G), control (C) and sham (S). Fetuses were evaluated for body weight (BW), intestinal (IW), liver (LW) and their relations IW/BW and LW/BW. IR-β and IGF-IRβ receptors, IRS-1 and IRS-2 substrates and Ikappaβ protein were analyzed by western blotting. RESULTS: BW was lower in G, the IW and IW / BW were greater than C and S (p<0.05) groups. The liver showed no differences between groups. In fetuses with gastroschisis, compared with control fetuses, the expression of IGF-IRβ (p<0.001) and Ikappaβ (p<0.001) increased in the liver and intestine, as well as IR-β (p<0.001) which decreased in both. In contrast to the intestine, IRS-1 (p<0.001) increased in the liver and IRS-2 decreased (p<0.01). CONCLUSION: The axis of the intestine liver has an important role in inflammation, with consequent changes in the metabolic pathway of glucose can contribute to the IUGR in fetuses with gastroschisis.
OBJETIVO: Avaliar a restrição de crescimento intra-uterino (RCIU) pela expressão de IR-β, IRS-1, IRS-2, IGF-IRβ e a via inflamatória do Ikappaβ no modelo de gastrosquise experimental. MÉTODOS: Ratas grávidas com 18,5 dias de gestação foram submetidas a cirurgia experimental para criar gastrosquise fetal (termo = 22 dias) e os fetos foram divididos em três grupos: gastrosquise (G), controle (C) e sham (S). Os fetos foram avaliados quanto ao peso corporal (BW), intestinal (IW), fígado (LW) e suas relações IW/BW e LW/BW. Os receptores IR-β e IGF-IRβ, os substratos IRS-1 e IRS-2 e a proteína Ikappaβ foram analisados por western blotting. RESULTADOS: O BW de G foi menor, o IW e IW/BW foram superiores a C e S (p < 0.05). O fígado não apresentou diferenças entre os grupos. Nos fetos com gastrosquise, quando comparados com fetos controles, a expressão de IGF-IRβ (p<0.001) e Ikappaβ (p<0.001) aumentou no fígado e intestino, assim como IR-β (p<0.001) que diminuiu em ambos. Inversamente ao intestino, IRS-1 (p<0.001) aumentou no fígado e IRS-2 diminuiu (p<0.01). CONCLUSÃO: O eixo do intestino fígado tem um papel importante na inflamação, com consequentes alterações na via metabólica de glicose que pode contribuir para a RCIU em fetos com gastrosquise.
Subject(s)
Animals , Female , Pregnancy , Rats , Fetal Growth Retardation/etiology , Gastrointestinal Tract/metabolism , Gastroschisis/complications , Liver/physiopathology , Receptor, Insulin/metabolism , Disease Models, Animal , I-kappa B Proteins/metabolism , Liver/metabolism , Rats, Sprague-DawleyABSTRACT
OBJECTIVE: Suspicious incidental gastrointestinal FDG uptake during positron-emission tomography/computed tomography (PET/CT) examinations can be caused by different diseases, including malignancies. However, differentiation with PET alone is difficult. The aim of this study was to investigate the potential of PET alone, contrast-enhanced CT (ceCT), and low-dose CT (ldCT) in routine PET/CT protocols for differentiation of incidental gastrointestinal lesions. MATERIALS AND METHODS: Sixty patients with incidental gastrointestinal lesions who underwent a routine PET/CT protocol with ldCT and ceCT were retrospectively analysed. The PET lesions were evaluated regarding their FDG uptake patterns and the standard uptake value. The anatomical correlates in both CT protocols were compared in regard to the correct lesion classification with the reference standard endoscopy. RESULTS: Sixty-two lesions were found in 60 patients (17 malignant, 10 premalignant, 5 benign, 13 inflammatory, 17 physiological). The differentiation of the FDG uptake patterns did not enable reliable lesion classification. The positive predictive value for pathology was 0.81 for ceCT in PET/CT and 0.70 for ldCT. Malignancies were detected in 100% of the patients by ceCT vs. 29.4% by ldCT. The false negative rate of ceCT for all pathologies was 31.1%, vs. 68.9% for ldCT. False positive results (17/62) could not be excluded sufficiently by either CT protocol. CONCLUSION: PET/ceCT protocols provide additional benefit especially in detecting gastrointestinal malignancies as a cause of suspicious incidental gastrointestinal FDG uptake. However, since follow-up endoscopy cannot be forgone due to the considerable false negative rate even with ceCT, the addition of ceCT to a routine PET/ldCT protocol cannot be recommended for this purpose.
Subject(s)
Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Contrast Media , Fluorodeoxyglucose F18 , Follow-Up Studies , Gastrointestinal Diseases/diagnosis , Gastrointestinal Tract/metabolism , Positron-Emission Tomography/methods , Reproducibility of Results , Retrospective Studies , Tomography, X-Ray Computed/methodsABSTRACT
Recently, the world's first transgenic dogs were produced by somatic cell nuclear transfer. However, cellular senescence is a major limiting factor for producing more advanced transgenic dogs. To overcome this obstacle, we rejuvenated transgenic cells using a re-cloning technique. Fibroblasts from post-mortem red fluorescent protein (RFP) dog were reconstructed with in vivo matured oocytes and transferred into 10 surrogate dogs. One puppy was produced and confirmed as a re-cloned dog. Although the puppy was lost during birth, we successfully established a rejuvenated fibroblast cell line from this animal. The cell line was found to stably express RFP and is ready for additional genetic modification.
Subject(s)
Animals , Female , Male , Animals, Genetically Modified , Cloning, Organism/methods , Dogs/genetics , Gastrointestinal Tract/metabolism , Gene Expression Regulation , Kidney/metabolism , Liver/metabolism , Luminescent Proteins/genetics , Lung/metabolism , Myocardium/metabolism , Nuclear Transfer Techniques/veterinary , Spleen/metabolism , Trachea/metabolismABSTRACT
Oral therapy utilizing cell microencapsulation has shown promise in the treatment of many diseases. Current obtainable microcapsule membranes, however, show inadequate stability in the gastrointestinal (GI) environment, thus restricting the general application of live cells for oral therapy. To overcome this limitation, we have previously developed a novel multi-layer alginate/poly-L-lysine/pectin/poly-L-lysine/alginate microcapsule (APPPA) with demonstrated improvement on membrane stability over the frequently reported alginate/poly-L-lysine/alginate (APA) microcapsules. In this study, we further examined the effects of preparation conditions on microcapsule formation, and assessed the membrane strength and GI stability. Results showed that increased membrane strength of the APPPA microcapsules was attained by using pectin with low degree of esterification as the mid-layer material, saline as the solvent for the preparation solutions and washing medium, and 0.1 M CaCl2 as the gelling solution for alginate cores. Resistance of this membrane to the simulated GI fluids was also investigated. Permeability of and release profiles from the APPPA microcapsules were found comparable to the APA microcapsules. These findings suggested that the multi-layer APPPA microcapsule formulation may have potential in oral delivery of proteins, live bacterial cells and other biomedical applications.
Subject(s)
Administration, Oral , Alginates/administration & dosage , Alginates/chemistry , Alginates/metabolism , Animals , Calcium Chloride/chemistry , Capsules , Cattle , Cell Membrane Permeability , Drug Compounding/methods , Drug Stability , Gastrointestinal Tract/metabolism , Pectins/chemistry , Sodium/chemistry , Sodium Chloride/chemistryABSTRACT
The purpose of the present work was the anatomical, histo logical and histochemical description oí Rhamdia quelen juvenile digestive system. Samples of gut were fixed, dehydrated and included in paraffin and then stained with haematoxylin and eosin. For the identification and differentiation of mucosubstances the preparations were treated with Periodic Acid Schiff, Alcian Blue pH 0,4 and 2,5 andPAS/AB pH 2,5. Anatomical details of the oesophagus were like a short tube with primary and secondary mucous folds. The stratified epithelium is composed of three cellular types: small cells, abundant goblet cells with acid and neutral mucosubstances (MS) and large acid cells. The stomach is J-shaped and its mucosa presents broad and deep folds in relaxing state. Histologically, the stomach shows three different regions: cardiac, fundic and pyloric region. The luminal surface of the epithelium consists of a layer of secretory columnar cells of neutral MS. Tubuloacinar glands were surrounded by connective and muscular smooth fibers bundle. The intestine extends from the stomach until the anus, and four different sections can be distinguished: ascending, descending, convoluta and terminal straight. It was identified a simple columnar epithelium mainly composed by two cellular types: absorptive cell and goblet cell neutral MS secretory. On the basis of the anatomical and histo logical study carried out, we conclude that R. quelen presents an alimentary canal compatible with species that possess omnivorous nutritious habits.
El propósito del presente trabajo fue realizar las descripciones anatómica, histológica e histoqufmica del sistema digestivo de Rhamdia quelen jóvenes. Las muestras de intestino fueron fijadas, deshidratadas e incluidas en parafina y posteriormente teñidas con hematoxilina y eosina. Para la identificación y diferenciación de muco substancias los preparados fueron tratados con ácido periódico de Schiff, Azul Alcian pH 0,4 y 2,5 y PAS/AB pH 2,5. Los detalles anatómicos del esófago mostraron un pequeño tubo con pliegues mucosos primarios y secundarios. El epitelio estratificado presentaba tres tipos celulares: células pequeñas, abundantes células caliciformes con muco substancia (MS) acida y neutra y células grandes acidas. El estómago tenía forma de J y su mucosa presenta pliegues amplios y profundos en estado de relajación. Histológicamente, el estómago mostraba tres diferentes regiones: cardiaca, fúndica y pilórica. La superficie luminal del epitelio constaba de una capa de células columnares secretoras de MS neutro. Glándulas tubuloacinares estaban rodeadas por tejido conjuntivo y fibras musculares lisas. El intestino se extendía desde el estómago hasta el ano, y cuatro diferentes secciones era posible distinguir: ascendente, descendente, convoluta y terminal recta. Se identificó un epitelio columnar simple, compuesto principalmente por dos tipos celulares: células de absorción y células caliciformes secretoras de MS neutra. Sobre la base de los estudios anatómico e histológico realizados, se concluye que R. quelen presenta un canal alimentario compatible con las especies que poseen hábitos nutritivos omnívoros.
Subject(s)
Animals , Gastrointestinal Tract/anatomy & histology , Gastrointestinal Tract/physiology , Gastrointestinal Tract/metabolism , Gastrointestinal Tract/chemistry , Catfishes , South AmericaABSTRACT
OBJETIVOS: A sepse é a principal causa de morte nas unidades de terapia intensiva. Recentemente, têm sido pesquisadas novas formas de prevenção e tratamento de infecção nosocomial, tais como o uso de pré e pró e simbióticos, devido as suas propriedades imunomoduladoras. O objetivo deste estudo foi avaliar o efeito da administração de pré, pro e simbióticos sobre a colonização de trato gastrintestinal e vias aéreas inferiores e sobre a incidência de infecções nosocomiais, particularmente pneumonia associada à ventilação mecânica. MÉTODOS: Pacientes em ventilação mecânica, internados na unidade de terapia intensiva do Hospital Universitário Clementino Fraga Filho entre novembro de 2004 e agosto de 2006, foram aleatorizados em quatro grupos: controle (n = 16), prebiótico (n = 10), probiótico (n = 12) e simbiótico (n = 11). O tratamento foi administrado por 14 dias. Foram avaliados: a) colonização do trato gastrintestinal e traquéia; b) incidência de infecções nosocomiais, principalmente pneumonia associada a ventilação mecânica; c) tempo de terapia antibiótica, ventilação mecânica, internação e letalidade na terapia intensiva e hospitalar; d) incidência de disfunções orgânicas. RESULTADOS: Foram avaliados 49 pacientes. A letalidade na terapia intensiva foi de 34 por cento, intra-hospitalar de 53 por cento e a mediana do APACHE II de 20 (13 - 25). Os grupos foram comparáveis na admissão. Houve aumento não significativo da proporção de enterobactérias em relação à de não fermentadores no sétimo dia na secreção traqueal nos grupos pré e probiótico e diminuição não-significativa do número de amostras no estômago nos grupos pré, pró e simbiótico no sétimo dia. Não houve diferença na incidência de pneumonia associada a ventilação mecânica, infecção nosocomial ou nos demais parâmetros. CONCLUSÕES: O uso de pré, pró e simbióticos não foi eficaz na prevenção de infecções nosocomiais, porém houve uma tendência de redução da colonização da secreção...
OBJECTIVES: Sepsis is the main cause of death in the intensive care unit. New preventive measures for nosocomial infections have been researched, such as pre, pro and symbiotic usage, due to its immunoregulatory properties. The objective was to evaluate the effect of administration of pre, pro and symbiotic on gastrointestinal and inferior airway colonization and on nosocomial infections, particularly ventilator-associated pneumonia. METHODS: Patients who were admitted to the intensive care unit at Hospital Universitário Clementino Fraga Filho between November 2004 and September 2006 and mechanically ventilated were randomized in one of four groups: control (n = 16), prebiotic (n = 10), probiotic (n = 12) or symbiotic (n = 11). Treatment was administered for fourteen days. Outcomes measured were: a) Colonization of the gastrointestinal tract and trachea; b) incidence of nosocomial infections, particularly ventilator associated pneumonia; c) duration of mechanical ventilation, length of stay in the intensive care unit, duration of hospitalization, mortality rates, and d) development of organ dysfunction. RESULTS: Forty-nine patients were evaluated. intensive care unit's mortality was 34 percent and in-hospital mortality was 53 percent, APACHE II median was 20 (13 -25). The groups were matched at admission. There was no difference between the groups in relation to the incidence of ventilator associated pneumonia or nosocomial infection. There was a non-significant increase in the proportion of enterobacteria in the trachea at the seventh day in the pre and probiotic groups compared to control. There was a non-significant decrease in the number of bacteria found in the stomach in the pre, pro and symbiotic group at day 7. No significant difference, in regards to the remaining measured parameters, could be found. CONCLUSIONS: Probiotic therapy was not efficient in the prevention of nosocomial infection but there was a tendency to reduction...
Subject(s)
Enteral Nutrition , Pneumonia, Ventilator-Associated , Probiotics/therapeutic use , Gastrointestinal Tract/metabolismABSTRACT
Desde o Diabetes Control and Complications Trial (DCCT), a terapia insulínica intensiva tem sido direcionada para alcançar valores de glicemia e hemoglobina glicada (HbA1c) tão próximos do normal quanto a segurança permita. Entretanto, a hiperglicemia (especialmente a hiperglicemia pós-prandial) e a hipoglicemia continuam a ser um problema no manejo do diabetes tipo 1. O objetivo de associar outras drogas à terapia insulínica é diminuir a glicemia pós-prandial. A terapia adjunta pode ser dividida em três grupos, conforme seu mecanismo de ação: 1. Aumento da ação da insulina (metformina e tiazolidinedionas); 2. Alteração da liberação de nutrientes no trato gastrintestinal (acarbose e amilina); 3. Outros modos de ação [pirenzepina, fator de crescimento insulina-símile (IGF-1) e peptídeo semelhante ao glucagon 1 (GLP-1). Muitos desses agentes mostraram, em estudos de curto prazo, diminuição de 0,5 por cento a 1 por cento na HbA1c, diminuir a hiperglicemia pós-prandial e as doses diárias de insulina.
Since Diabetes Control and Complications Trial (DCCT), intensive therapy has been directed at achieving glucose and glycosylated hemoglobin (HbA1c) values as close to normal as possible regarding safety issues. However, hyperglycemia (especially postprandial hyperglycemia) and hypoglicemia continue to be problematic in the management of type 1 diabetes. The objective of associating other drugs to insulin therapy is to achieve better metabolic control lowering postprandial blood glucose levels. Adjunctive therapies can be divided in four categories based on their mechanism of action: enhancement of insulin action (e.g. the biguanides and thiazolidinediones), alteration of gastrointestinal nutrient delivery (e.g. acarbose and amylin) and other targets of action (e.g. pirenzepine, insulin-like growth factor I and glucagon-like peptide-1). Many of these agents have been found to be effective in short-term studies with decreases in HbA1c of 0.5-1 percent, lowering postprandial blood glucose levels and decreasing daily insulin doses.
Subject(s)
Humans , Blood Glucose/drug effects , Diabetes Mellitus, Type 1/drug therapy , Glycated Hemoglobin/metabolism , Hypoglycemic Agents/therapeutic use , Insulin/therapeutic use , Thiazolidinediones/therapeutic use , Acarbose/metabolism , Acarbose/therapeutic use , Amyloid/metabolism , Amyloid/therapeutic use , Drug Therapy, Combination , Diabetes Mellitus, Type 1/metabolism , Gastrointestinal Tract/drug effects , Gastrointestinal Tract/metabolism , Glucagon-Like Peptide 1/analogs & derivatives , Glucagon-Like Peptide 1/metabolism , Glucagon-Like Peptide 1/therapeutic use , Hyperglycemia/drug therapy , Hyperglycemia/metabolism , Hypoglycemia/drug therapy , Incretins/metabolism , Incretins/therapeutic use , Insulin-Like Growth Factor I/metabolism , Insulin-Like Growth Factor I/therapeutic use , Metformin/therapeutic use , Muscarinic Antagonists/metabolism , Muscarinic Antagonists/therapeutic use , Postprandial Period , Pirenzepine/metabolism , Pirenzepine/therapeutic useABSTRACT
Prokinetic drugs like mosapride, domperidone etc, are used to treat gastrointestinal delay. Though the receptor-mediated actions of these agents have been studied, involvement of ion channels in reversing morphine-induced gastrointestinal inertia by prokinetic agents has not been explored. Charcoal meal test was used to measure small intestinal transit (SIT) in adult male Swiss albino mice. Animals were given ion channel modifiers and prokinetic drugs intragastrically. Reversal of morphine-induced gastrointestinal delay by mosapride was decreased significantly by CaCl2, minoxidil and glibenclamide. Similarly, domperidone's effect on morphine was decreased by CaCl2, nifedipine, minoxidil and glibenclamide significantly. The results reveal that ion channel modifiers counteract the prokinetic effects of mosapride or domperidone.
Subject(s)
Analgesics, Opioid/pharmacology , Animals , Benzamides/pharmacology , Calcium Channels/metabolism , Domperidone/pharmacology , Gastrointestinal Tract/metabolism , Glyburide/pharmacology , Intestine, Small/drug effects , Ion Channels/metabolism , Kinetics , Mice , Minoxidil/pharmacology , Morphine/pharmacology , Morpholines/pharmacology , Nifedipine/pharmacology , Time FactorsABSTRACT
La fibra alimentaria (FA) ha sido un tópico de considerable interés para los nutricionistas y médicos en estos últimos 35 años. Este artículo presenta un análisis sobre la definición de fibra alimentaria y la controversia que existe al respecto, así como las nuevas propuestas que han surgido para incluir en su definición. La FA fue definida como: todos los polisacáridos no almidones más la lignina, que no pueden ser digeridos o absorbidos en el intestino delgado humano. Esta definición no incluye otros componentes vegetales tales como: polifenoles, proteínas resistentes y almidones resistente, los cuales son también resistentes a la digestión. Para muchos investigadores, la definición de FA aun no esta concluida o completa. Las investigaciones epidemiológicas han indicado, la posible relación entre las enfermedades más comunes en las modernas sociedades occidentales y la fibra alimentaria.
Dietary fiber (DF) has been a topic of considerable interest among nutritionists and physicians for the last 35 years. This work was basically focused on an analysis of the dietary fiber definition, the currently existing controversy and the new proposal to be included in such a definition. DF was defined as all nonstarch polysaccharides plus lignin, which are not digested or absorbed in the human digestive tract. This definition does not include other vegetable substances, such as, polyphenols, resistant protein or resistant starch, which are also resistant to digestion. For most researchers this definition is not yet complete. Epidemiological investigations, have suggested the possible relationship between the most common diseases in the modern Western societies and the dietary fiber.
Subject(s)
Humans , Dietary Carbohydrates/blood , Dietary Carbohydrates/chemical synthesis , Dietary Fiber/administration & dosage , Dietary Fiber/history , Dietary Fiber/metabolism , Gastrointestinal Tract/metabolism , Nutritional Sciences , Phenolic Compounds , Polysaccharides/metabolism , Plants/chemistryABSTRACT
Freqüentemente recorre-se à produção de sistemas gastrorretentivos para modular a liberação de fármacos a partir de sistemas farmacêuticos com vistas ao aumento do tempo de permanência do fármaco no trato gastrointestinal. Umas das estratégias mais interessantes passa pela produção de sistemas flutuantes. Estes podem ser classificados em dois grupos: sistemas flutuantes efervescentes e sistemas flutuantes não-efervecentes. Neste artigo apresenta-se uma revisão bibliográfica do que tem sido produzido nesta área nos últimos anos.
Gastro-retentive systems are often produced in order to modulate drugs release from pharmaceutical forms and in this way to increase drug residence time in the gastrointestinal tract. One of the most interesting strategies consists in the preparation of floating devices. These can be classified into two groups: effervescent systems and non-effervescent systems. A review of what has been done in the last years is presented in this article.
Subject(s)
Drug Delivery Systems , Pharmaceutical Preparations/administration & dosage , Gastrointestinal Tract/metabolism , Biological AvailabilityABSTRACT
Matrizes hidrofílicas de diclofenaco sódico e de cetoprofeno foram preparadas por meio de compressão direta ou granulação úmida seguida de compressão, utilizando-se hipromelose para modular a dissolução do fármaco. Foram também obtidos péletes de liberação prolongada de cetoprofeno, mediante extrusão-esferonização e revestimento, em leito fluidizado, com Kollicoat® EMM 30D. Um planejamento fatorial 22 foi usado para elucidar os efeitos de variáveis de formulação sobre os perfis de liberação do fármaco a partir dos sistemas em estudo, determinados empregando-se os métodos da pá e/ou Bio-Dis. No caso dos comprimidos matriciais, os efeitos do grau de viscosidade e concentração de hipromelose foram investigados. Para os péletes, avaliou-se os efeitos da granulometria e ganho de peso em revestimento. A influência do pH sobre a liberação do fármaco a partir dos sistemas preparados foi também estudada, usando-se meios de dissolução com pH 1,2-7,2. Os métodos ANOVA e teste de Tukey (comparação estatística entre porcentuais de fármaco dissolvido e/ou eficiência de dissolução), f1, f2 e Weibull foram usados para caracterizar e comparar os perfis de dissolução. O grau de viscosidade e concentração de hipromelose influenciaram a liberação de diclofenaco sádico e cetoprofeno a partir das matrizes em estudo, sendo a concentração do polímero o fator principal que governou o processo. A granulação alterou os perfis de dissolução de cetoprofeno em relação às matrizes obtidas por compressão direta, diminuindo a velocidade e modificando o mecanismo de liberação. No caso dos péletes, o ganho de peso em revestimento foi o parâmetro que exerceu maior efeito sobre a liberação do cetoprofeno, enquanto a granulometria apenas influenciou os perfis de dissolução dás formulações com maior ganho de peso em revestimento. A liberação do fármaco a partir dos sistemas em estudo aumentou com a elevação do pH, o que ocorreu devido à solubilidade pH-dependente do cetoprofeno e diclofenaco sódico.
Diclofenac sodium and ketoprofen hydrophilic matrices were prepared by direct compression or wet granulation followed by compression, using hypromellose to modulate the drug dissolution. Sustained release ketoprofen pellets were also obtained by extrusion-spheronization and fluidized bed coating with Kollicoat® EMM 30D. A 22 factorial design has been used to elucidate the effects of formulation variables on the drug release profiles from the systems in study, determined using the paddle method and Bio-Dis. In the case of matrix tablets, the effects of the viscosity grade and concentration of hypromellose were investigated. For the pellets, the effects of granulometry and weight gain were evaluated. The influence of the pH value on the drug release from the prepared systems was also studied, using pH 1,2-7,2 dissolution media. ANOVA and Tukey's test (statistical comparison between percentages of drug dissolved and/or dissolution efficiency), f1, f2 and Weibull methods were used to characterize and compare the dissolution profiles. The concentration and viscosity grade of hypromellose influenced the ketoprofen and diclofenac sodium release from the studied matrices, being the polymer concentration the main factor that has governed the process. Granulation has modified the dissolution profiles of ketoprofen in relation to the matrices obtained by direct compression, reducing the rate and modifying the mechanism of drug release. In the pellets case, weight gain was the main factor that has influenced the ketoprofen release, while ganulometry has only influenced the dissolution profiles of the formulation with the highest weight gain. Drug release from the systems under study increased with the increase of the pH value of the medium because of the diclofenac sodium and ketoprofen pH-dependent solubility.